Identification of adverse drug events the use of ICD-10 coded diagnoses in routine hospital data;Erkennung von unerwünschten arzneimittelereignissen: Nutzung von ICD-10-codierten diagnosen in routinedaten von krankenhäusern

Deutsches Arzteblatt

Volumn 107, Issue 3, 2010, Pages 23-29

  Stausberg, Jürgen ^a   Hasford, Joerg ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIPARKINSON AGENT; ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT; GASTROINTESTINAL AGENT; HORMONE; HORMONE ANTAGONIST; NARCOTIC AGENT; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ADVERSE DRUG REACTION; AGRANULOCYTOSIS; ANAPHYLACTOID PURPURA; ANGIONEUROTIC EDEMA; ARTICLE; COLITIS; DRUG HYPERSENSITIVITY; ENTEROCOLITIS; EVALUATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GASTROENTERITIS; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPOTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; INTOXICATION; MEDICAL LITERATURE; NEUTROPENIA; RASH;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG TOXICITY; GERMANY; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PATIENT ADMISSION; PRESCRIPTIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 77949498589     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2010.0023     Document Type: Article

References (20)

1. Muehlberger N, Schneeweiss S, Hasford J: Adverse drug reaction monitoring - cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admission. Pharmaco - epidemiol Drug Saf 1997; 6 Suppl 3: 71-7.
2. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective stud ies. JAMA 1998; 279: 1200-05.
3. Pirmohamed M, James S, Meakin S, et al.: Adverse drug reactions as cause of admission to hospital: a prospective analysis of 18820 patients. BMJ 2004; 329: 15-9.
4. Kongkaew C, Noyce PR, Ashcroft DM: Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42: 1017-25.
5. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M: Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439.
6. Goettler M, Schneeweiss S, Hasford J: Adverse drug reaction monitoring - cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6 Suppl 3: 79-90.
7. Solberg LI, Hurley JS, Roberts MH, et al.: Measuring patient safety in ambulatory care: potential for identifying medical group drug - drug interaction rates using claims data. Am J Manag Care 2004; 10: 753-9.
8. Waller P, Shaw M, Ho D, Shakir S, Ebrahim S: Hospital admis sions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. British Journal of Clinical Pharmacology 2004; 59: 213-9.
9. Sachverständigenrat zur Begutachtung der Entwicklung im Ge - sundheitswesen: Kooperation und Verantwortung. Voraussetzungen einer zielorientierten Gesundheitsversorgung. Gutachten 2007. www.svr-gesundheit.de/ (last accessed on December 16, 2008).
10. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling A-K, Avorn J: Admissions caused by adverse drug events to internal med icine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285-91.
11. Deutsche Krankenhausgesellschaft, Spitzenverbände der Kranken - kassen, Verband der privaten Krankenversicherung, Institut für das Entgeltsystem im Krankenhaus: Allgemeine und Spezielle Kodierrichtlinien für die Verschlüsselung von Krankheiten und Prozeduren, Version 2006. Institut für das Entgeltsystem im Krankenhaus 2005.
12. Zhang M, Holman CD'AJ, Preen DB, Brameld K: Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol 2006; 63: 163-70.
13. Houchens RL, Elixhauser A, Romano PS: How often are potential patient safety events present on admission? The Joint Commission Journal on Quality and Patient Safety 2008; 34: 154-63.
14. Brennan TA, Leape LL, Laird NM, et al.: Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Med ical Practice Study I. NEJM 1991; 324: 370-6.
15. Aktionsbündnis Patientensicherheit (eds.): Agenda Patientensicherheit 2007. Witten: April 2007.
16. Schrappe M, Lessing C, Schmitz A, et al. (eds.): Agenda Patientensicherheit 2008. Witten: November 2008.
17. Nebeker JR, Yarnold PR, Soltysik RC, et al.: Developing indicators of inpatient drug events through nonlinear analysis using administra - tive data. Medical Care 2007; 45: 81-8.
18. Field TS, Gurwitz JH, Harrold LR, et al.: Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc 2004; 11: 492-8.
19. Stausberg J: Die Kodierqualität in der stationären Versorgung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2007; 50: 1039-46.
20. Stausberg J, Dahmen B, Drösler SE: A methodological framework for the conversion of procedure classifications. Meth Inf Med 2005; 44: 57-65.